These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22886530)

  • 21. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
    Liu M; Zhou K; Huang Y; Cao Y
    J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
    Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.
    Burns SS; Akhmametyeva EM; Oblinger JL; Bush ML; Huang J; Senner V; Chen CS; Jacob A; Welling DB; Chang LS
    Cancer Res; 2013 Jan; 73(2):792-803. PubMed ID: 23151902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-18b modulates insulin-like growth factor-1 expression in deer antler cell proliferation by directly targeting its 3' untranslated region.
    Hu W; Li M; Hu R; Li T; Meng X
    DNA Cell Biol; 2015 Apr; 34(4):282-9. PubMed ID: 25756952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.
    Bie L; Zhao G; Ju Y; Zhang B
    Cancer Genet; 2011 Oct; 204(10):536-40. PubMed ID: 22137483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and epigenetic alterations in meningiomas.
    Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
    Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells.
    Zhang J; Liu Z; Dong Y
    Dis Markers; 2022; 2022():6423237. PubMed ID: 35818586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of miR-106b suppresses the growth of human glioma cells.
    Zhang A; Hao J; Wang K; Huang Q; Yu K; Kang C; Wang G; Jia Z; Han L; Pu P
    J Neurooncol; 2013 Apr; 112(2):179-89. PubMed ID: 23377830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
    Dalan AB; Gulluoglu S; Tuysuz EC; Kuskucu A; Yaltirik CK; Ozturk O; Ture U; Bayrak OF
    BMC Cancer; 2017 Mar; 17(1):207. PubMed ID: 28327132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LINC00702/miR-4652-3p/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt/β-catenin pathway.
    Li T; Ren J; Ma J; Wu J; Zhang R; Yuan H; Han X
    Biomed Pharmacother; 2019 May; 113():108718. PubMed ID: 30849635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape.
    Kiliç T; Bayri Y; Ozduman K; Acar M; Diren S; Kurtkaya O; Ekinci G; Buğra K; Sav A; Ozek MM; Pamir MN
    Neurosurgery; 2002 Jul; 51(1):183-92; discussion 192-3. PubMed ID: 12182416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.
    Iwami K; Natsume A; Ohno M; Ikeda H; Mineno J; Nukaya I; Okamoto S; Fujiwara H; Yasukawa M; Shiku H; Wakabayashi T
    Neuro Oncol; 2013 Jun; 15(6):747-58. PubMed ID: 23460320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.
    Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M
    Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
    Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
    Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b.
    Wan Y; Sun G; Wang Z; Guo J; Shi L
    Neuroreport; 2014 Mar; 25(5):289-96. PubMed ID: 24356103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quercetin induces apoptosis in meningioma cells through the miR-197/IGFBP5 cascade.
    Hu SA; Cheng J; Zhao WH; Zhao HY
    Environ Toxicol Pharmacol; 2020 Nov; 80():103439. PubMed ID: 32585423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
    Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
    Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.